These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9653466)

  • 1. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Joffe P; Thomsen HS; Meusel M
    Acad Radiol; 1998 Jul; 5(7):491-502. PubMed ID: 9653466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of gadodiamide in patients with severe renal insufficiency treated conservatively or undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Joffe P; Thomsen HS
    Acad Radiol; 2011 Aug; 18(8):1060. PubMed ID: 21718957
    [No Abstract]   [Full Text] [Related]  

  • 3. Dialyzability of gadodiamide in hemodialysis patients.
    Saitoh T; Hayasaka K; Tanaka Y; Kuno T; Nagura Y
    Radiat Med; 2006 Jul; 24(6):445-51. PubMed ID: 16958426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the elimination and safety of gadodiamide injection in patients with hemodialysis].
    Abe M; Kuno T; Takahashi Y; Nagura Y; Matsumoto K
    Nihon Jinzo Gakkai Shi; 2004; 46(8):810-4. PubMed ID: 15645738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
    Berg KJ; Lundby B; Reinton V; Nordal KP; Rootwelt K; Smith HJ
    Nephron; 1996; 72(2):212-7. PubMed ID: 8684529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
    Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
    Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadodiamide administration causes spurious hypocalcemia.
    Prince MR; Erel HE; Lent RW; Blumenfeld J; Kent KC; Bush HL; Wang Y
    Radiology; 2003 Jun; 227(3):639-46. PubMed ID: 12773671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: Prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function.
    Bridges MD; St Amant BS; McNeil RB; Cernigliaro JG; Dwyer JP; Fitzpatrick PM
    AJR Am J Roentgenol; 2009 Jun; 192(6):1538-43. PubMed ID: 19457816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
    Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
    Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
    Lorusso V; Taroni P; Alvino S; Spinazzi A
    Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
    Burgess ED; Gill MJ
    J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
    Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
    Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
    Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
    Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
    Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE; Frey FJ; Heizmann P; Brandt R; Weidekamm E
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.